NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 978 | 2021 |
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 436 | 2020 |
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention F Bishehsari, M Mahdavinia, M Vacca, R Malekzadeh, ... World journal of gastroenterology: WJG 20 (20), 6055, 2014 | 343 | 2014 |
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science Translational Medicine 12 (572), 2020 | 321 | 2020 |
Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease V Azzu, M Vacca, S Virtue, M Allison, A Vidal-Puig Gastroenterology 158 (7), 1899-1912, 2020 | 277 | 2020 |
Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The Lancet Gastroenterology & Hepatology 7 (5), 388-390, 2022 | 215 | 2022 |
Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease Z Hall, NJ Bond, T Ashmore, F Sanders, Z Ament, X Wang, AJ Murray, ... Hepatology 65 (4), 1165-1180, 2017 | 184 | 2017 |
Pericardial adipose tissue regulates granulopoiesis, fibrosis, and cardiac function after myocardial infarction M Horckmans, M Bianchini, D Santovito, RTA Megens, JY Springael, ... Circulation 137 (9), 948-960, 2018 | 162 | 2018 |
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor–null mice by intestinal‐specific farnesoid X receptor reactivation C Degirolamo, S Modica, M Vacca, G Di Tullio, A Morgano, A D'Orazio, ... Hepatology 61 (1), 161-170, 2015 | 125 | 2015 |
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice GL Sasso, F Bovenga, S Murzilli, L Salvatore, G Di Tullio, N Martelli, ... Gastroenterology 144 (7), 1497-1507. e13, 2013 | 125 | 2013 |
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil S D'Amore, M Vacca, M Cariello, G Graziano, A D'Orazio, R Salvia, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2016 | 118 | 2016 |
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma Z Hall, D Chiarugi, E Charidemou, J Leslie, E Scott, L Pellegrinet, ... Hepatology 73 (3), 1028-1044, 2021 | 117 | 2021 |
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption FWB Sanders, A Acharjee, C Walker, L Marney, LD Roberts, F Imamura, ... Genome biology 19, 1-15, 2018 | 115 | 2018 |
Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease O Govaere, SK Petersen, N Martinez-Lopez, J Wouters, M Van Haele, ... Journal of hepatology, 2021 | 110 | 2021 |
Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis M Vacca, M Di Eusanio, M Cariello, G Graziano, S D'Amore, FD Petridis, ... Cardiovascular research 109 (2), 228-239, 2016 | 104 | 2016 |
Down‐regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes G Lo Sasso, N Celli, M Caboni, S Murzilli, L Salvatore, A Morgano, ... Hepatology 51 (4), 1334-1344, 2010 | 100 | 2010 |
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome M Vacca, C Degirolamo, R Mariani‐Costantini, G Palasciano, ... Wiley Interdisciplinary Reviews: Systems Biology and Medicine 3 (5), 562-587, 2011 | 90 | 2011 |
Fatty acid and glucose sensors in hepatic lipid metabolism: implications in NAFLD M Vacca, M Allison, JL Griffin, A Vidal-Puig Seminars in liver disease 35 (03), 250-261, 2015 | 81 | 2015 |
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts M Petruzzelli, M Vacca, A Moschetta, RC Sasso, G Palasciano, ... Clinical biochemistry 40 (8), 503-510, 2007 | 63 | 2007 |
Primary sclerosing cholangitis: updates in diagnosis and therapy P Portincasa, M Vacca, A Moschetta, M Petruzzelli, G Palasciano, ... World Journal of Gastroenterology: WJG 11 (1), 7, 2005 | 60 | 2005 |